Hyundai Bioscience leads in the repurposing of Niclosamide
- Thursday, April 8, 2021, 4:45
- PR Newswire
- Add a comment
SEOUL, South Korea, April 8, 2021 /PRNewswire/ — A research paper by a South Korean bio tech company that demonstrated the drug repurposing of Niclosamide, an anthelmintic known to have excellent therapeutic efficacy against novel coronavirus infection (COVID-19), was published in the…
About the Author
admin has written 20551 stories on this site.